U.S., Aug. 8 -- ClinicalTrials.gov registry received information related to the study (NCT07108738) titled 'Pomegranate Peel Extract for Primary Molar Pulpotomy' on July 31.
Brief Summary: Pomegranate peel extract has demonstrated a range of potential uses in the biomedical industry in recent years because of its numerous benefits, which include anti-inflammatory, antibacterial, anti-apoptotic, antioxidant, and cell-regeneration-promoting qualities. Therefore, the purpose of this study will be to evaluate the clinical and radiographic efficacy of Pomegranate peel extract as a pulpotomy agent in primary teeth.
Study Start Date: Aug., 2025
Study Type: INTERVENTIONAL
Condition:
Pulpitis Reversible
Pulp Exposure, Dental
Intervention:
PRO...